CID 3390254

(25s)-5beta-spirostan-3beta-ol 3-o-beta-d-glucoside

Structural Information

Molecular Formula
C33H54O8
SMILES
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)O)O)C)C)C)OC1
InChI
InChI=1S/C33H54O8/c1-17-7-12-33(38-16-17)18(2)26-24(41-33)14-23-21-6-5-19-13-20(8-10-31(19,3)22(21)9-11-32(23,26)4)39-30-29(37)28(36)27(35)25(15-34)40-30/h17-30,34-37H,5-16H2,1-4H3
InChIKey
ZNEIIZNXGCIAAL-UHFFFAOYSA-N
Compound name
2-(hydroxymethyl)-6-(5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl)oxyoxane-3,4,5-triol
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

22
Patents

578.3819 Da
Monoisotopic Mass

4.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 579.38918 238.6
[M+Na]+ 601.37112 241.5
[M+NH4]+ 596.41572 248.2
[M+K]+ 617.34506 236.5
[M-H]- 577.37462 243.9
[M+Na-2H]- 599.35657 232.3
[M]+ 578.38135 240.5
[M]- 578.38245 240.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe